Global rare disease policy shifts are reshaping orphan drug development, with major implications for equitable access in the UK, EU and US.

An examination of the emerging antitrust risks associated with the rise of AI, including the state of US regulation and key antitrust enforcement concerns.

Taking risks builds confidence. Research and real stories from Sara Haines and Diane Farr show why decisive action is the foundation of strong leadership growth.

AI agents support multi-million-dollar decisions by mirroring humans. Here's what it takes for them to operate in high-stakes environments.

Leadership accountability is not just about holding others responsible. It is also about creating the conditions, systems, ...